Cargando…
Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose
BACKGROUND/AIMS: Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease. Calcium dobesilate (CaD) is widely used to treat diabetic retinopathy. Recent studies have demonstrated that CaD exerts protective effects against diabetic nephropathy. The aim of this study was to elucidat...
Autores principales: | Zhou, Yijun, Qi, Chaojun, Li, Shu, Shao, Xinghua, Ni, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855025/ https://www.ncbi.nlm.nih.gov/pubmed/31780874 http://dx.doi.org/10.1155/2019/9893682 |
Ejemplares similares
-
Calcium dobesilate may alleviate diabetes-induced endothelial dysfunction and inflammation
por: Zhou, Yijun, et al.
Publicado: (2017) -
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017) -
Calcium dobesilate-induced hyperpyrexia: A case report
por: Yang, Hui, et al.
Publicado: (2023) -
Calcium Dobesilate (CaD) Attenuates High Glucose and High Lipid-Induced Impairment of Sarcoplasmic Reticulum Calcium Handling in Cardiomyocytes
por: Deng, Jianxin, et al.
Publicado: (2021)